FindTrial
Sign In

Early risk stratification of the novel coronavirus infected diseases (COVID-19): a multicenter retrospective study (ERS-COVID-19 study)

Early risk stratification of the novel coronavirus disease 2019 (COVID-19): a multicenter retrospective study (ERS-COVID-19 study)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030494
Enrollment
Unknown
Registered
2020-03-05
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia 2019 (COVID-19)

Interventions

Novel coronavirus pneumonia:none

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Aged >18 years old; 2. patients diagnosed COVID-19.

Exclusion criteria

Exclusion criteria: 1. Patients without complete clinical data; 2. Give up treatment and discharge patients automatically.

Design outcomes

Primary

MeasureTime frame
mortality;—

Secondary

MeasureTime frame
Tracheal cannula;admission to ICU;Multiple organ dysfunction syndrome;Myocardial injury;acute kidney injury;Severe pneumonia;—

Countries

China

Contacts

Public ContactRui Zeng

West China Hospital, Sichuan University

zengrui_0524@126.com+86 028-85423248

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026